PHARMACIST INTERVENTION ON IDENTIFICATION OF DRUG INTERACTIONS IN TERTIARY CARE HOSPITALS

Journal Title: International Journal of Pharmacy and Pharmaceutical Sciences - Year 2018, Vol 10, Issue 10

Abstract

Objective: The aim of this study was to assess the potential drug interactions (pDIs) among hospitalized patients in cardiac and neurology wards in 3 tertiary care hospitals.Methods: A prospective, observational study was carried out for a period of 12 mo. A sample of 1330 patients was assessed for pDDIs using Micromedex®-2.7and drugs.com and www.dugs.com.Results: A total of 1330 patients were analyzed and it was found that 685 were cardiac and 645 were neurology patients. The study identified 524 (76.49%) cardiac patients and 425 (65.89%) neurology patients, with potential drug-drug interactions (pDDIs) higher in male cardiac [298 (56.87%)] and male neurology [235 (55.29%)] patients, compared to females. Incidences of pDDIs were found to be higher in the age group of 60-70 y in cardiac [193 (36.83%)] and neurology [165 (38.84%)] patients and incidences of interactions based on duration of (4-6 d) hospital stays in cardiac were 380 (72.53%) and 275 (64.70%) in neurology patients respectively. Moreover, 51.90% cardiac patients and 57.41% neurology patients were found to be prescribed with more number of drugs in cardiac and neurology (7 drugs) patients, were found to have developed higher incidences of pDDIs. The most common drug interacting pair was between aspirin and clopidogrel combination, observed in 245 cardiac and 316 in neurology patients. Drug-food interactions (DFIs) were found with between atorvastatin-citrus fruits in cardiac and phenytoin-protein rich foods in neurology patients. The most common drug-disease interaction (D-DIs) was found to between isosorbide dinitrate–myocardial infarction in cardiac and carbamazepine-seizuresin neurology respectively.Conclusion: It is recommended that physicians should be aware of the interactions among those drugs while prescribing, and careful monitoring is also required.

Authors and Affiliations

Kameswaran R. , Shanmuga Sundaram Rajagopal, Krishnaveni Kandasamy, Karthikeyan Krishnan

Keywords

Related Articles

MILK WHEY PROTEINS MODULATE ENDOTOXEMIA-INDUCED HEPATOTOXICITY IN RATS

Objective: The therapeutic effects of whey protein isolate (WPI), alpha-lactalbumin (a-LA) and beta-lactoglobulin (β-LG) against endotoxemia-induced hepatotoxicity were investigated in female rats.Methods: Endotoxemia w...

COMPUTATIONAL INTERACTION OF ENTOMOPATHOGENIC FUNGAL SECONDARY METABOLITES WITH PROTEINS INVOLVED IN HUMAN XENOBIOTIC DETOXIFICATION

Objective: Entomopathogenic fungi are rich source of secondary metabolites which posses both pharmacological and insecticidal activity. It is essential to assess metabolite toxicity of chemically diverse toxic metabolite...

ANTIBACTERIAL ACTIVITY OF MORINGA OLEIFERA (LAM) LEAVES EXTRACTS AGAINST SOME SELECTED BACTERIA

Objective: The antibacterial activity of Moringa oleifera (Lam.) Leaves extract belonging to the family Moringaceae, was determined using agar well diffusion method against some selected bacteria. Methods: Mueller Hinton...

NON PITTING TYPE PEDAL EDEMA WITH LITHIUM: A CASE REPORT

Objective: To report a case of lithium induced bilateral nonpitting pedal edema.Methods: The clinical data of a bipolar affective disorder patient with current episode of mania and psychotic symptoms who experienced bila...

IN VITRO ANTIBACTERIAL ACTIVITIES OF MARINE SPONGE-ASSOCIATED BACTERIA AGAINST PATHOGENIC VIBRIO SPP. CAUSES VIBRIOSIS IN SHRIMPS

Objective: This study was aimed to isolate and screen marine sponge-associated bacteria producing anti-Vibrio compounds and to identify their compounds from the bacterial extract. Methods: Sponge-associated bacteria wer...

Download PDF file
  • EP ID EP566123
  • DOI 10.22159/ijpps.2018v10i10.28399
  • Views 68
  • Downloads 0

How To Cite

Kameswaran R. , Shanmuga Sundaram Rajagopal, Krishnaveni Kandasamy, Karthikeyan Krishnan (2018). PHARMACIST INTERVENTION ON IDENTIFICATION OF DRUG INTERACTIONS IN TERTIARY CARE HOSPITALS. International Journal of Pharmacy and Pharmaceutical Sciences, 10(10), 23-29. https://europub.co.uk/articles/-A-566123